The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths globally, owing to its high recurrence rate of 50 to 70% within five years. Despite known associations of certain DNA damage and repair (DDR) genes with tumor recurrence and drug resistance, a comprehensive...
Saved in:
| Main Authors: | Jiayao Ma, Diya Tang, Guangzu Cui, Xiangyang Zhang, Xinwen Wang, Yin Li, Erya Hu, Xin Zhou, Haicong Liu, Qingping Peng, Changjing Cai, Xiangying Deng, Shan Zeng, Yihong Chen, Zemin Xiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-99853-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01) -
The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma
by: Xin Zhou, et al.
Published: (2025-06-01) -
Multi-omics analysis identifies SNP-associated immune-related signatures by integrating Mendelian randomization and machine learning in hepatocellular carcinoma
by: Qingyan Kou, et al.
Published: (2025-07-01) -
Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
by: Gelan Zhu, et al.
Published: (2024-12-01) -
A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
by: Zhang Z, et al.
Published: (2025-04-01)